Pharmaceutical behemoths will soon begin clinical trials for blockbuster obesity drugs in children as young as six years old.Eli Lilly, which makes Mounjaro, and Novo Nordisk, which manufactures Wegovy and Ozempic, are going to begin recruiting kids in the near future, though an exact timeline is unknown. Wegovy is already Food and Drug Administration-approved for obese children 12 and older, but Mounjaro has only gained approval to treat .
Load More
Load More